全文获取类型
收费全文 | 7688篇 |
免费 | 569篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 74篇 |
儿科学 | 137篇 |
妇产科学 | 159篇 |
基础医学 | 1007篇 |
口腔科学 | 138篇 |
临床医学 | 966篇 |
内科学 | 1512篇 |
皮肤病学 | 159篇 |
神经病学 | 624篇 |
特种医学 | 267篇 |
外科学 | 1238篇 |
综合类 | 68篇 |
一般理论 | 5篇 |
预防医学 | 736篇 |
眼科学 | 97篇 |
药学 | 491篇 |
中国医学 | 10篇 |
肿瘤学 | 585篇 |
出版年
2023年 | 67篇 |
2022年 | 113篇 |
2021年 | 346篇 |
2020年 | 195篇 |
2019年 | 272篇 |
2018年 | 304篇 |
2017年 | 209篇 |
2016年 | 203篇 |
2015年 | 286篇 |
2014年 | 310篇 |
2013年 | 421篇 |
2012年 | 565篇 |
2011年 | 594篇 |
2010年 | 282篇 |
2009年 | 227篇 |
2008年 | 370篇 |
2007年 | 347篇 |
2006年 | 357篇 |
2005年 | 281篇 |
2004年 | 266篇 |
2003年 | 252篇 |
2002年 | 221篇 |
2001年 | 146篇 |
2000年 | 143篇 |
1999年 | 108篇 |
1998年 | 59篇 |
1997年 | 48篇 |
1996年 | 43篇 |
1995年 | 48篇 |
1994年 | 23篇 |
1993年 | 28篇 |
1992年 | 81篇 |
1991年 | 79篇 |
1990年 | 78篇 |
1989年 | 72篇 |
1988年 | 59篇 |
1987年 | 48篇 |
1986年 | 49篇 |
1985年 | 65篇 |
1984年 | 40篇 |
1983年 | 29篇 |
1979年 | 45篇 |
1978年 | 27篇 |
1974年 | 33篇 |
1973年 | 29篇 |
1972年 | 30篇 |
1970年 | 23篇 |
1969年 | 23篇 |
1968年 | 28篇 |
1966年 | 27篇 |
排序方式: 共有8273条查询结果,搜索用时 15 毫秒
81.
Carla Dillon Justin Peddle Laurie Twells Kendra Lester William Midodzi Kimberley Manning Raleen Murphy David Pace Chris Smith Darrell Boone Deborah Gregory 《The Canadian journal of hospital pharmacy》2015,68(2):113-120
Background:
Patients who have undergone bariatric surgery generally need fewer medications as they experience improvement in, or even resolution of, various medical conditions, including type 2 diabetes mellitus, hypertension, and dyslipidemia. Published data on changes in medication use after laparoscopic sleeve gastrectomy, a type of bariatric surgery that is growing in popularity, are limited.Objective:
To determine whether patients took fewer medications for management of type 2 diabetes, hypertension, and dyslipidemia after laparoscopic sleeve gastrectomy, relative to preprocedure medications.Methods:
In this prospective, single-centre cohort study, a nurse practitioner used standard medication reconciliation and study data-extraction forms to interview adult patients who had undergone laparoscopic sleeve gastrectomy and determine their medication use and pertinent demographic data. The data were analyzed using generalized estimating equations and standard statistical software. Outcome measures included changes in the use of antidiabetic, antihypertensive, and antilipemic medications at 1, 3, and 6 months after the surgery.Results:
A total of 65 patients who underwent laparoscopic sleeve gastrectomy between May 2011 and January 2014 met the study inclusion criteria. Before surgery, the 30 patients with type 2 diabetes were taking an average of 1.9 antidiabetic medications. One month after the procedure, 15 (50%) had discontinued all antidiabetic medications, with a further decline at 3 and 6 months (p < 0.001 at each time point). Among the patients who were taking antihypertensives (n = 48) and antilipemics (n = 33) before surgery, the decline in use occurred at a more modest rate, with 6 (12%) and 2 (6%), respectively, discontinuing these medication classes within 1 month, and 12 (25%) (p = 0.001) and 8 (24%) (p = 0.015) having discontinued by 6 months.Conclusions:
These findings suggest that patients with a history of type 2 diabetes mellitus, hypertension, and/or dyslipidemia who undergo laparoscopic sleeve gastrectomy are less likely to require disease-specific medications shortly after surgery. 相似文献82.
83.
84.
Lindsay M Yager Kyle K Pitchers Shelly B Flagel Terry E Robinson 《Neuropsychopharmacology》2015,40(5):1269-1277
A discrete cue associated with intravenous injections of cocaine acquires greater control over motivated behavior in some rats (‘sign-trackers'', STs) than others (‘goal-trackers'', GTs). It is not known, however, if such variation generalizes to cues associated with other drugs. We asked, therefore, whether a discrete cue (a light) associated with the intravenous administration of an opioid drug (the short-acting mu receptor agonist, remifentanil) acquires incentive motivational properties differently in STs and GTs, as indicated by tests of Pavlovian conditioned approach and conditioned reinforcement. Consistent with studies using cocaine, STs approached a classically conditioned opioid cue more readily than GTs, and in a test of conditioned reinforcement worked more avidly to get it. Interestingly, STs and GTs did not differ in the acquisition of a conditioned orienting response. In addition, the performance of conditioned approach behavior, but not conditioned orientation, was attenuated by pretreatment with the dopamine receptor antagonist, flupenthixol, into the core of the nucleus accumbens. Lastly, food and opioid cues engaged similar amygdalo–striatal–thalamic circuitry to a much greater extent in STs than GTs, as indicated by Fos expression. Taken together, these data demonstrate that, similar to food and cocaine cues: (1) a discrete opioid cue attains greater incentive motivational value in STs than GTs; (2) the attribution of incentive motivational properties to an opioid cue is dopamine dependent; and (3) an opioid cue engages the so-called ‘motive circuit'' only if it is imbued with incentive salience. 相似文献
85.
86.
Martin D. Rosenthal Jayshil Patel Kyle Staton Robert G. Martindale Frederick A. Moore Gilbert R. UpchurchJr 《Current gastroenterology reports》2018,20(9):40
Purpose of the Review
Fish oil (FO) supplementation has historically been used by individuals suffering from cardiovascular disease and other inflammatory processes. However, a meta-analysis of several large randomized control trials (RCTs) suggested FO conferred no benefit in reducing cardiovascular risk. Skeptics surmised that the lack of benefit was related to FO dose or drug interactions; therefore, the widely accepted practice of FO consumption was brought into question.Recent Findings
Thereafter, Serhan et al. identified specialized pro-resolving mediators (SPMs) to be one of the bioactive components and mechanisms of action of FO. SPMs are thought to enhance resolution of inflammation, as opposed to classic anti-inflammatory agents which inhibit inflammatory pathways. Numerous diseases, including persistent Inflammation, immunosuppression, and catabolic syndrome (PICS), are rooted in a burden of chronic inflammation. SPMs are gaining traction as potential therapeutic agents used to resolve inflammation in cardiovascular disorders, inflammatory bowel disease, sepsis, pancreatitis, and acute respiratory distress syndrome (ARDS).Summary
This narrative reviews the history of FO and the various studies that made the health benefits of FO inconclusive, as well as an overview of SPMs and their use in specific disease states.87.
PURPOSE: Patients with systemic capillary leak syndrome have a characteristic triad of hypotension, hemoconcentration, and monoclonal gammopathy. They have frequent and severe attacks of hemoconcentration and hypotension accompanied by marked plasma shifts. The exact role of this monoclonal protein is unknown, but it probably leads, in some way, to an increase in capillary permeability. Despite efforts to resuscitate the patients during an acute attack, the syndrome is often fatal. Some success has been obtained in preventing the attacks with the beta-adrenergic-stimulating agent terbutaline. The purpose of this study was to determine the effectiveness of aminophylline and terbutaline in the treatment of systemic capillary leak syndrome. METHODS: Over a decade, three patients with systemic capillary leak syndrome presented at our institution. All three patients were treated with terbutaline and aminophylline. Prednisone was used during the course of treatment in each of the three patients. RESULTS: In contrast to previous reports of partial or temporary control of episodes, all three patients are alive with almost complete resolution of their recurrent attacks and have been able to return to their normal lifestyles. CONCLUSION: The regimen of terbutaline and aminophylline effectively prevents the attacks of hypotension and hemoconcentration that occur in systemic capillary leak syndrome. The role of prednisone is not clear. Until more is known about the pathophysiology of the disorder, treatment must remain empiric and supportive. 相似文献
88.
R A Kyle 《The American journal of medicine》1978,64(5):814-826
Two hundred forty-one patients with a monoclonal protein in the serum but initially no evidence of multiple myeloma, macroglobulinemia, amyloidosis or lymphoma were followed up for more than five years. At the conclusion of the studies the patients were classified as follows: Group 1, patients without significant increase in monoclonal protein, 57 per cent; group 2, patients with more than 50 per cent increase in monoclonal serum protein or development of monoclonal urine protein, 9 per cent; group 3, patients who died without five-year serum studies, 23 per cent; and group 4, patients in whom myeloma, macroglobulinemia or amyloidosis developed, 11 per cent. Initially, the hemoglobin level, size of serum monoclonal protein peak, number of plasma cells in the bone marrow and levels of normal immunoglobulins were not significantly different among the four groups. The median interval from recognition of the monoclonal protein to diagnosis of multiple myeloma was 64 months, of macroglobulinemia 103 months and of amyloidosis 92 months. A significant increase of the monoclonal protein or development of myeloma, macroglobulinemia or amyloidosis occurred in 18 per cent of the patients with monoclonal immunoglobulin G(IgG), in 28 per cent with immunoglobulin A (IgA) and in 25 per cent with immunoglobulin M (IgM). Retrospective analysis of age, sex, presence of organomegaly, hemoglobin level, size and type of serum monoclonal protein peak, presence of small amounts monoclonal light chain in the urine, serum albumin level, levels of uninvolved immunoglobulins, IgG subclass and level of plasma cells in the bone marrow did not show how to distinguish initially between stable benign disease and progressive disease. Therefore, periodic reexamination of patients with monoclonal gammopathy is essential. 相似文献
89.
Increased amounts of the Aspergillus metabolite D-mannitol in tissue and serum of rats with experimental aspergillosis 总被引:4,自引:0,他引:4
Several Aspergillus species produce large amounts of the hexitol D-mannitol in vitro, but it is not known whether these species also produce D-mannitol in vivo. Serum samples and homogenized tissues were analyzed from rats pretreated with cortisone and cyclophosphamide and then given 2 x 10(6) preincubated conidia of Aspergillus fumigatus intravenously. The resulting infection was lethal by 48 h and was characterized by much more severe disease in the liver than in the kidneys, spleen, or lungs. A compound present in increased amounts in the livers and sera of the infected rats was shown to be D-mannitol by gas chromatography (GC) and GC/mass spectrometry and enzymatically. Quantitative analysis by GC showed that the infected rats had more D-mannitol in their livers (but not in their lungs or kidneys) after 12 h (P less than .01 at 12, 24, and 36 h) and higher serum D-mannitol concentrations and serum D-mannitol/creatinine ratios after 36 h (P less than .05) than did uninfected controls. These results indicate that A. fumigatus can produce and release sufficient D-mannitol in the tissues of infected animals to raise serum D-mannitol levels. Thus, D-mannitol is a potential diagnostic marker for aspergillosis. 相似文献
90.